Reaktion #1519104

ord-88b0a74555e84873b24100e1678debb4

Reaktionsgleichung

Oc1cc(-c2cc(Cl)ccn2)nc(-c2ccccn2)n1
6-(4-chloropyrid-2-yl)-2-pyrid-2-yl-pyrimidin-4-ol
CN1CCNCC1
1-methyl-piperazine
CN1CCN(c2ccnc(-c3cc(O)nc(-c4ccccn4)n3)c2)CC1
6-[4-(4-Methyl-piperazin-1-yl)-pyrid-2-yl]-2-pyrid-2-yl-pyrimidin-4-ol

Lösungsmittel

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Temperaturis refluxed for 22 hours
  2. 2
    Einengenconcentrated to dryness
  3. 3
    Sonstigea rotary evaporator
  4. 4
    workup.ADDITION50 ml of water are added
  5. 5
    workup.ADDITION3.6 g of EDTA are added
  6. 6
    ExtraktionExtraction
  7. 7
    Trocknendried (sodium sulfate)
  8. 8
    EinengenConcentration
  9. 9
    Sonstigea rotary evaporator
  10. 10
    Sonstigethe crude product is recrystallised from toluene

Vorschrift

A mixture of 3.51 g (12.3 mmol) of 6-(4-chloropyrid-2-yl)-2-pyrid-2-yl-pyrimidin-4-ol, 27.4 ml (303 mmol, 20 equivalents, 30.38 g) of 1-methyl-piperazine and 84 mg (0.05 mmol, 0.05 equivalent) of zinc(II) chloride in 50 ml of 2-methyl-2-butanol is refluxed for 22 hours and concentrated to dryness using a rotary evaporator. 50 ml of water are added, 3.6 g of EDTA are added, and the pH is adjusted to 9 using dilute sodium hydroxide solution. Extraction is carried out three times using 150 ml of chloroform each time, and the organic extracts are combined and dried (sodium sulfate). Concentration is carried out using a rotary evaporator and the crude product is recrystallised from toluene. 6-[4-(4-Methyl-piperazin-1-yl)-pyrid-2-yl]-2-pyrid-2-yl-pyrimidin-4-ol is obtained in the form of a whitish solid.

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07612010B2uspto-grants-2009_11